Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anteris Technologies Global Corp. Director's Dealing 2009

Jun 11, 2009

33869_rns_2009-06-11_3f5d61dd-11b6-4b6d-a94d-8c395088c958.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [595 x 64] intentionally omitted <==

Innovative BioMedical Devices

Level 11, 225 St Georges Terrace Telephone (08) 9262 6777 bioMD Limited ABN 35 088 221 078 Facsimile (08) 9322 3433 Perth, Western Australia 6000 PO Box 7209, Cloisters Square www.biomd.com.au Western Australia 6850

ANNOUNCEMENT TO THE AUSTRALIAN STOCK EXCHANGE

1 of 2 pages

12 June 2009

Company Announcements Office Australian Stock Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Dear Sir/Madam

Re: Appendix 3Y – Change in Director’s Interest Notice

The Directors of bioMD Ltd wish to advise of a change to the notifiable interests of a director in accordance with Listing Rule 3.19A.1 and section 205G of the Corporations Act.

Please refer to the ‘Appendix 3Y’ attached for details of the change.

Yours faithfully

==> picture [78 x 59] intentionally omitted <==

Caroline Bentley Company Secretary

==> picture [595 x 42] intentionally omitted <==

APPENDIX 3Y

CHANGE OF DIRECTOR’S INTEREST NOTICE

Name of Entity: bioMD Limited ABN: 35 055 221 078

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Robert Towner Date of last notice: 4 April 2009

PART 1 – Change of director's relevant interests in securities

Direct or indirect interest: Direct / Indirect Nature of indirect interest: Mr Towner is a director of a company holding BOD Date of change: 26 May 2009 No. of securities held prior to change: Ordinary shares–16,981,992 (indirect), 630,000 (direct) Class: Listed ordinary shares (BOD) Number acquired: 5,057,500 shares (direct) Number disposed: 5,057,500 (indirect) Value/Consideration: $Nil No. of securities held after change: Ordinary shares11,924,492 (indirect) and 5,687,500 (direct) Nature of the change: Off-market transfer between holdings – no change to beneficial ownership. PART 2 – Change of director’s interests in contracts Details of contract: None Applicable Nature of interest: Name of registered holder: (if issued securities) No. and class of securities to which interest relates: Interest acquired: Interest disposed: Value/Consideration: Interest after change: